MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
886.32%
Quick Ratio
886.32%
Cash Ratio
91.67%
Debt to Asset Ratio
11.51%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Long-term borrowing
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
48,599
52,547
48,301
35,260
Marketable securities
412,471
452,800
457,136
293,700
Prepaid expenses and other current assets
8,806
7,882
10,015
5,369
Total current assets
469,876
513,229
515,452
334,329
Operating lease right-of-use assets
638
921
1,146
1,419
Other assets and long-term deposits
16,064
16,495
16,832
16,705
Total assets
486,578
530,645
533,430
352,453
Accounts payable
1,667
3,719
9,253
3,474
Operating lease liabilities, current
660
956
1,124
1,168
Other current liabilities
50,687
42,492
41,425
37,013
Total current liabilities
53,014
47,167
51,802
41,655
Operating lease liabilities, net of current portion
0
0
69
310
Long-term borrowing
3,000
3,000
3,000
3,000
Total liabilities
56,014
50,167
54,871
44,965
Common stock, 0.0001 par value 490,000,000 shares authorized as of june 30, 2026 and december 31, 2025 87,452,166 and 81,376,449 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
8
8
8
7
Additional paid-in capital
1,145,349
1,131,576
1,075,487
858,451
Accumulated other comprehensive (loss) income
-947
-460
621
526
Accumulated deficit
-713,846
-650,646
-597,557
-551,496
Total stockholders' equity
430,564
480,478
478,559
307,488
Total liabilities and stockholders' equity
486,578
530,645
533,430
352,453
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$412,471K (33.30%↑ Y/Y)Cash and cashequivalents$48,599K (-7.38%↓ Y/Y)Prepaid expenses andother current assets$8,806K (51.51%↑ Y/Y)Total current assets$469,876K (27.78%↑ Y/Y)Other assets andlong-term deposits$16,064K (27.57%↑ Y/Y)Operating leaseright-of-use assets$638K (-62.14%↓ Y/Y)Total assets$486,578K (27.38%↑ Y/Y)Total liabilities andstockholders' equity$486,578K (27.38%↑ Y/Y)Total stockholders'equity$430,564K (24.72%↑ Y/Y)Total liabilities$56,014K (52.35%↑ Y/Y)Accumulated deficit-$713,846K (-40.17%↓ Y/Y)Accumulated othercomprehensive (loss) income-$947K (-401.59%↓ Y/Y)Additional paid-in capital$1,145,349K (34.09%↑ Y/Y)Total currentliabilities$53,014K (59.85%↑ Y/Y)Long-term borrowing$3,000K (0.00%↑ Y/Y)Common stock, 0.0001par value...$8K (14.29%↑ Y/Y)Other currentliabilities$50,687K (63.10%↑ Y/Y)Accounts payable$1,667K (78.48%↑ Y/Y)Operating leaseliabilities, current$660K (-42.76%↓ Y/Y)

Olema Pharmaceuticals, Inc. (OLMA)

Olema Pharmaceuticals, Inc. (OLMA)